干细胞移植治疗视网膜变性疾病临床试验现状及前景

刘勇

doi:10.16016/j.1000-5404.201807157

您当前的位置：

首页 >

文章列表页 >

干细胞移植治疗视网膜变性疾病临床试验现状及前景

专家述评 | 更新时间：2026-03-02

- 干细胞移植治疗视网膜变性疾病临床试验现状及前景
- Stem cell transplantation for retinal degeneration: current status and future prospects
- 第三军医大学学报 2019年41卷第3期页码：187-191
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)第一附属医院全军眼科中心，视觉损伤与再生修复重庆市重点实验室Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China
- 作者简介：
- 基金信息：
  
  国家重点研发计划(2016YFC1101103)
- DOI：10.16016/j.1000-5404.201807157
  中图分类号： R617;R774.1
- 收稿：2018-07-21，
  
  纸质出版：2019-02-15
- 稿件说明：
移动端阅览
刘勇. 干细胞移植治疗视网膜变性疾病临床试验现状及前景[J]. 第三军医大学学报, 2019,41(3):187-191.

Yong LIU. Stem cell transplantation for retinal degeneration: current status and future prospects[J]. Journal of Third Military Medical University, 2019, 41(3): 187-191.
刘勇. 干细胞移植治疗视网膜变性疾病临床试验现状及前景[J]. 第三军医大学学报, 2019,41(3):187-191. DOI： 10.16016/j.1000-5404.201807157.

Yong LIU. Stem cell transplantation for retinal degeneration: current status and future prospects[J]. Journal of Third Military Medical University, 2019, 41(3): 187-191. DOI： 10.16016/j.1000-5404.201807157.

摘要

Abstract

Age-related macular degeneration (AMD) and retinitis pigmentosa (RP)

characterized by dysfunction and loss of retinal pigment epithelium (RPE) and photoreceptors and then retinal degeneration

are major causes of blindness. Currently

there is still no curable treatment available. Recent clinical trials showed that stem cell therapy provided a safe and promising efficiency for these retinal diseases. Transplantation of human embryonic stem cells (hESCs) and induced pluripotent stem (iPS) cells have obtained safe outcomes for RPE replacement and achieved certain efficacy in treatment of AMD. Fetal retinal progenitor cells for photoreceptor replacement have also confirmed long-term safety and feasibility in vision repair for RP patients. However

there still exist some challenges in this field

including developing novo transplantation technique

ensuring long-term cellular survival and promoting the integration of transplanted cells into the retina. This article provided an analysis of ongoing studies and challenges ahead in this aspect.

关键词

Keywords

references

BULL N D, MARTIN K R. Concise review: toward stem cell-based therapies for retinal neurodegenerative diseases[J]. Stem Cells, 2011, 29(8): 1170-1175.DOI: 10.1002/stem.676.

MACLAREN R E, PEARSON R A, MACNEIL A, et al. Retinal repair by transplantation of photoreceptor precursors[J]. Nature, 2006, 444(7116): 203-207.DOI: 10.1038/nature05161.

SCHWARTZ S D, HUBSCHMAN J P, HEILWELL G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report[J]. Lancet, 2012, 379(9817): 713-720.DOI: 10.1016/S0140-6736(12)60028-2.

YE H, ZHANG Q, LIU X, et al. Prevalence of age-related macular degeneration in an elderly urban chinese population in China: the Jiangning eye study[J]. Invest Ophthalmol Vis Sci, 2014, 55(10): 6374-6380.DOI: 10.1167/iovs.14-14899.

SONG W K, PARK K M, KIM H J, et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients[J]. Stem Cell Reports, 2015, 4(5): 860-872.DOI: 10.1016/j.stemcr.2015.04.005.

MANDAI M, WATANABE A, KURIMOTO Y, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration[J]. N Engl J Med, 2017, 376: 1038-1046.DOI:10.1056/NEJMoa1608368.

DA CRUZ L, FYNES K, GEORGIADIS O, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration[J]. Nat Biotechnol, 2018, 36(4): 328-337.DOI: 10.1038/nbt.4114.

LIU Y, XU H W, WANG L, et al. Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration[J]. Cell Discovery, 2018. [Epub ahead of print].

MEHAT M S, SUNDARAM V, RIPAMONTI C, et al. Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration[J]. Ophthalmology, 2018. [Epub ahead of print].DOI: 10.1016/j.ophtha.2018.04.037.

BERTOLOTTI E, NERI A, CAMPARINI M, et al. Stem cells as source for retinal pigment epithelium transplantation[J]. Prog Retin Eye Res, 2014, 42: 130-144.DOI: 10.1016/j.preteyeres.2014.06.002.

SCHWARTZ S D, REGILLO C D, LAM B L, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies[J]. Lancet, 2015, 385(9967): 509-516.DOI: 10.1016/S0140-6736(14)61376-3.

NAZARI H, ZHANG L, ZHU D, et al. Stem cell based therapies for age-related macular degeneration: The promises and the challenges[J]. Prog Retin Eye Res, 2015, 48: 1-39.DOI: 10.1016/j.preteyeres.2015.06.004.

LIU Y, CHEN S J, LI S Y, et al. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients[J]. Stem Cell Res Ther, 2017, 8(1): 209.DOI: 10.1186/s13287-017-0661-8.

SHAO J, ZHOU P Y, PENG G H. Experimental study of the biological properties of human embryonic stem cell-derived retinal progenitor cells[J]. Sci Rep, 2017: 42363.

ZHONG X, GUTIERREZ C, XUE T, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs[J]. Nat Commun, 2014: 4047.

KAMAO H, MANDAI M, OKAMOTO S, et al. Characteri-zation of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application[J]. Stem Cell Reports, 2014, 2(2): 205-218.DOI: 10.1016/j.stemcr.2013.12.007.

PETRUS-REURER S, BARTUMA H, ARONSSON M, et al. Integration of subretinal suspension transplants of human embryonic stem cell-derived retinal pigment epithelial cells in a large-eyed model of geographic atrophy[J]. Invest Ophthalmol Vis Sci, 2017, 58(2): 1314-1322.DOI: 10.1167/iovs.16-20738.

SINGH M S, CHARBEL ISSA P, BUTLER R, et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation[J]. Proc Natl Acad Sci U S A, 2013, 110(3): 1101-1106.DOI: 10.1073/pnas.1119416110.

TIAN C, ZHAO T, ZENG Y, et al. Increased müller cell de-differentiation after grafting of retinal stem cell in the sub-retinal space of Royal College of Surgeons rats[J]. Tissue Eng Part A, 2011, 17(19/20): 2523-2532.DOI: 10.1089/ten.TEA.2010.0649.

ZHAO T, ZHANG Z N, RONG Z, et al. Immunogenicity of induced pluripotent stem cells[J]. Nature, 2011, 474: 212-215.

DE VOCHT N, LIN D, PRAET J, et al. Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain[J]. Immunobiology, 2013, 218(5): 696-705.DOI: 10.1016/j.imbio.2012.08.266.

SHIMAZAKI J, AIBA M, GOTO E, et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders[J]. Ophthalmology, 2002, 109(7): 1285-1290.

RADTKE C, REDEKER J, JOKUSZIES A, et al. In vivo transformation of neural stem cells following transplantation in the injured nervous system[J]. J Reconstr Microsurg, 2010, 26(3): 211-212.DOI: 10.1055/s-0029-1238221.

LAMBA D, GUST J, REH T. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice[J]. Cell Stem Cell, 2009, 4(1): 73-79.DOI: 10.1016/j.stem.2008.10.015.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

视神经损伤诱导小胶质细胞表型变化与视网膜神经节细胞死亡的关系

直流电场对人脂肪间充质干细胞增殖和干细胞生物学特性的影响

Nogo66蛋白复合物对慢性高眼压大鼠视网膜微环境的影响

Notch通路参与调控成年小鼠c-kit⁺视网膜前体细胞分裂和分化修复NMDA视网膜损伤

太赫兹辐射暴露引起小鼠视网膜基因表达改变